drugset / Trial / NCT02592356
Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer
NaSingle-groupOpen-labelSupportive care
Summary
The goal of this clinical research study is to learn about possible weight, muscle, and/or fat loss in patients receiving cabozantinib or lenvatinib.
Timeline
- Start
- 2015-11-16
- Primary completion
- 2024-03-01
- Completion
- 2024-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Cabozantinib | Small molecule | — | — |
| Background | Lenvatinib | Small molecule | — | — |